We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+5.44%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$145M
AUM Growth
+$8.65M
Cap. Flow
+$1.37M
Cap. Flow %
0.94%
Top 10 Hldgs %
22.7%
Holding
101
New
2
Increased
42
Reduced
31
Closed
2

Top Buys

Rank Stock Value
1
MOS icon
The Mosaic Company
MOS
+$1.64M
2
BBH icon
VanEck Biotech ETF
BBH
+$519K
3
STT icon
State Street
STT
+$441K
4
MA icon
Mastercard
MA
+$274K
5
OMC icon
Omnicom Group
OMC
+$267K

Sector Composition

Rank Sector Weight
1 Industrials 14.79%
2 Technology 13.37%
3 Consumer Staples 10.59%
4 Financials 10.11%
5 Healthcare 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XYL icon
26
Xylem
XYL
$28.5B
$2.31M 1.6%
59,212
-1,620
-3% -$60.5K
SPY icon
27
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$2.3M 1.59%
11,761
-1,605
-12% -$305K
COP icon
28
ConocoPhillips
COP
$147B
$2.28M 1.57%
26,580
+180
+0.7% +$14K
UPS icon
29
United Parcel Service
UPS
$97.6B
$2.27M 1.57%
22,091
+460
+2% +$46.2K
XLU icon
30
State Street Utilities Select Sector SPDR ETF
XLU
$24.1B
$2.25M 1.56%
101,880
-1,412
-1% -$30K
ACN icon
31
Accenture
ACN
$89.9B
$2.19M 1.51%
27,071
+1,660
+7% +$133K
HYG icon
32
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$2.16M 1.49%
22,676
-232
-1% -$21.9K
BNY
33
Bank of New York Mellon
BNY
$108B
$2.1M 1.45%
55,950
+1,462
+3% +$50.6K
CL icon
34
Colgate-Palmolive
CL
$72.6B
$2.05M 1.42%
30,140
-740
-2% -$49.6K
CVS icon
35
CVS Health
CVS
$137B
$2.04M 1.41%
27,047
-1,278
-5% -$96.6K
EWC icon
36
iShares MSCI Canada ETF
EWC
$6.04B
$1.99M 1.38%
61,815
-1,140
-2% -$34.9K
CMCSK
37
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$1.93M 1.34%
36,273
-1,020
-3% -$54.4K
VB icon
38
Vanguard Small-Cap ETF
VB
$79.5B
$1.88M 1.3%
16,010
-348
-2% -$38.9K
ADP icon
39
Automatic Data Processing
ADP
$100B
$1.86M 1.28%
26,695
-2,164
-7% -$148K
EFA icon
40
iShares MSCI EAFE ETF
EFA
$76.4B
$1.84M 1.28%
26,990
+746
+3% +$51.1K
OIH icon
41
VanEck Oil Services ETF
OIH
$2.06B
$1.84M 1.27%
1,592
-27
-2% -$28.5K
OMC icon
42
Omnicom Group
OMC
$22.7B
$1.78M 1.23%
25,024
+3,840
+18% +$267K
DE icon
43
Deere & Co
DE
$170B
$1.75M 1.21%
19,342
+1,070
+6% +$98.4K
IJR icon
44
iShares Core S&P Small-Cap ETF
IJR
$109B
$1.74M 1.2%
31,110
+1,390
+5% +$75.2K
ABBV icon
45
AbbVie
ABBV
$458B
$1.74M 1.2%
30,854
+3,282
+12% +$172K
MOS icon
46
The Mosaic Company
MOS
$7.09B
$1.65M 1.14%
+33,360
New +$1.64M
T icon
47
AT&T
T
$165B
$1.61M 1.11%
60,417
-2,118
-3% -$56.7K
CVX icon
48
Chevron
CVX
$388B
$1.51M 1.05%
11,611
+462
+4% +$57.5K
STT icon
49
State Street
STT
$50.9B
$1.49M 1.03%
22,096
+6,700
+44% +$441K
XLE icon
50
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
$1.48M 1.02%
29,520
-204
-0.7% -$9.65K

Similar funds

Boston Research & Management's Q2 2014 Portfolio in Review

As of Q2 2014, Boston Research & Management held 101 positions worth $145M, up 6.4% from $136M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q2 2014: portfolio turnover was 4%. Boston Research & Management opened 2 new positions and exited 2, leaving the 101-position portfolio largely intact.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Consumer Staples.

  • Boston Research & Management's largest Q2 2014 buy was The Mosaic Company: 33,360 shares worth $1.65M.
  • Boston Research & Management added most to VanEck Biotech ETF in Q2 2014, an estimated $519K increase.
  • Boston Research & Management's biggest Q2 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $305K.
  • Boston Research & Management fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2014, selling an estimated $1.93M.
  • Boston Research & Management's ten largest holdings make up 23% of its $145M portfolio in Q2 2014.
  • Boston Research & Management opened 2 new positions and closed 2 in Q2 2014.
  • Boston Research & Management's portfolio value rose 6.4% quarter-over-quarter to $145M.

Based on Boston Research & Management's 13F filing for Q2 2014, filed 12 Aug 2014.